Active Ingredient History
Riboflavin, also known as vitamin B2, is a vitamin found in food and sold as a dietary supplement. It is essential to the formation of two major coenzymes, flavin mononucleotide and flavin adenine dinucleotide. These coenzymes are involved in energy metabolism, cellular respiration, and antibody production, as well as normal growth and development. The coenzymes are also required for the metabolism of niacin, vitamin B6, and folate. Riboflavin is prescribed to treat corneal thinning, and taken orally, may reduce the incidence of migraine headaches in adults. Wikipedia
Combination drugs
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Acidosis, Lactic (Phase 4)
Acquired Immunodeficiency Syndrome (Phase 4)
Alcoholism (Phase 2)
Alcohol Withdrawal Delirium (Phase 2/Phase 3)
Amyotrophic Lateral Sclerosis (Phase 1)
Arthritis, Rheumatoid (Phase 1/Phase 2)
Autoimmune Diseases (Phase 1/Phase 2)
Burning Mouth Syndrome (Early Phase 1)
Burns, Chemical (Phase 1/Phase 2)
Central Serous Chorioretinopathy (Phase 2)
Chronic Pain (Phase 2)
Cognition Disorders (Phase 2)
Cognitive Dysfunction (Phase 3)
Compliance (Phase 2)
Corneal Diseases (Phase 4)
Corneal Neovascularization (Phase 2/Phase 3)
Corneal Ulcer (Phase 2/Phase 3)
Coronavirus Infections (Phase 3)
COVID-19 (Phase 3)
Crohn Disease (Phase 3)
Deficiency Diseases (Phase 2/Phase 3)
Delayed Emergence from Anesthesia (Phase 2)
Delirium (Phase 2)
Dermatology (Phase 1)
Diabetes Mellitus (Phase 4)
Diabetic Neuropathies (Phase 3)
Dilatation, Pathologic (Phase 3)
Esophageal Mucosa (Early Phase 1)
Fatigue (Phase 4)
Gastric Antral Vascular Ectasia (Phase 2)
Gastrointestinal Microbiome (Phase 2)
Head Injuries, Closed (Phase 3)
Healthy Volunteers (Phase 1)
Hematologic Diseases (Phase 3)
Hepatitis B, Chronic (Phase 4)
HIV Infections (Phase 4)
Infections (Phase 3)
Ischemic Stroke (Phase 2)
Keratectomy (Phase 3)
Keratitis (Phase 4)
Keratoconus (Phase 4)
Lipodystrophy (Phase 4)
Lupus Erythematosus, Systemic (Phase 1/Phase 2)
Magnesium Deficiency (Phase 2/Phase 3)
Malnutrition (Early Phase 1)
Myalgia (Early Phase 1)
Mycobacterium tuberculosis (Phase 3)
Myocardial Infarction (Phase 2)
Myopia (Phase 2)
Neoplasms (Phase 3)
Neurocognitive Disorders (Phase 2)
Nutrition Disorders (Phase 2)
Obesity (Phase 4)
Oral Ulcer (Phase 3)
Pemphigoid, Benign Mucous Membrane (Phase 1/Phase 2)
Psoriasis (Phase 2)
Refractive Errors (Phase 2)
Sports Medicine (Phase 2)
Steatitis (Phase 4)
Stevens-Johnson Syndrome (Phase 1/Phase 2)
Stomach Neoplasms (Early Phase 1)
Stroke (Phase 3)
Ureteral Diseases (Early Phase 1)
Uterine Cervical Neoplasms (Phase 1/Phase 2)
Wernicke Encephalopathy (Phase 2/Phase 3)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
